Literature DB >> 31348518

Survival and specific outcome of sickle cell disease patients after renal transplantation.

Christel Gérardin1,2, Anissa Moktefi2,3, Cécile Couchoud4, Alyette Duquesne5, Nacera Ouali6, Philippe Gataut7, Alexandre Karras8, Dany Anglicheau9,10, Carmen Lefaucheur11, Lucile Figueres12, Laetitia Albano13, Arnaud Lionet14, Marine Novion15, Marie-Julia Ziliotis16, Magali Louis17, Arnaud Del Bello18, Marie Matignon1,2, Karine Dahan19, Anoosha Habibi20,21, Frederic Galacteros20,21, Pablo Bartolucci20,21, Philippe Grimbert1,2, Vincent Audard1,2.   

Abstract

The prognosis of sickle cell disease (SCD) patients who need dialysis is poor, but experience with kidney transplantation is limited. This study assessed the characteristics of 36 SCD patients undergoing renal transplantation. Immediate post-surgical complications occurred in 25% of cases. Cytomegalovirus and bacterial infections were frequently observed. Twelve patients died after a median follow-up period of 17·4 months. Overall patient survival was significantly lower in SCD than in the control group without significant difference for overall death-censored graft survival. Our data suggest that renal transplantation should be systematically considered in SCD patients with end-stage renal disease.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  infections; patient survival; renal transplantation; sickle cell disease

Year:  2019        PMID: 31348518     DOI: 10.1111/bjh.16113

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Kidney Transplantation in Sickle Cell Disease Patients: Case Series and Experience from a Nigerian Kidney Transplant Center.

Authors:  Martin Igbokwe; Olalekan Olatise; Adegboyega Faponle; Abayomi Aremu; Vasanth Revanur; Habiba Jiwoh; Omotola Obajolowo; Idaomeh Ameh
Journal:  Indian J Nephrol       Date:  2022-03-09

Review 2.  The nephropathy of sickle cell trait and sickle cell disease.

Authors:  Kenneth I Ataga; Santosh L Saraf; Vimal K Derebail
Journal:  Nat Rev Nephrol       Date:  2022-02-21       Impact factor: 42.439

3.  American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.

Authors:  Robert I Liem; Sophie Lanzkron; Thomas D Coates; Laura DeCastro; Ankit A Desai; Kenneth I Ataga; Robyn T Cohen; Johnson Haynes; Ifeyinwa Osunkwo; Jeffrey D Lebensburger; James P Lash; Theodore Wun; Madeleine Verhovsek; Elodie Ontala; Rae Blaylark; Fares Alahdab; Abdulrahman Katabi; Reem A Mustafa
Journal:  Blood Adv       Date:  2019-12-10

Review 4.  Advances in the diagnosis and treatment of sickle cell disease.

Authors:  A M Brandow; R I Liem
Journal:  J Hematol Oncol       Date:  2022-03-03       Impact factor: 17.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.